Loading provider…
Loading provider…
Ophthalmology Physician in Oceanside, NY
NPI: 1558366526Primary Employer
Ophthalmic Consultants of Long Island
ocli.net
HQ Phone
Mobile
Get M.D. Glenn's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
New York Presbyterian Hospital
Residency • Ophthalmology
1992 - 1995
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92250Photography of the retina | 1,362 | 1,730 |
| 2 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 1,307 | 1,872 |
| 3 | 92235Imaging of blood vessels in back of eye using fluorescein dye | 1,041 | 1,197 |
| 4 | 92134Diagnostic imaging of retina | 829 | 2,340 |
| 5 | 67028Injection of drug into eye | 514 | 2,382 |
Clinical Use of Home OCT Data to Manage Neovascular Age-Related Macular Degeneration.
Authors: Ankoor Shah, Yingna Liu, Moises Chica, Kevin Blinder, Nikolas London, Konstantin Astafurov, Jordana Fein, Thomas Margolis, Jay Wang, Miguel Busquets, Paul Hahn
Journal: J Vitreoretin Dis
Publication Date: 2024-12-07
Prevention of ocular scarring after glaucoma filtering surgery using the monoclonal antibody LT1009 (Sonepcizumab) in a rabbit model.
Authors: Ashley Beattie, Zachary Lukowski, Mark Sherwood
Publication Date: 2011-09-28
Anatomical benefit from ranibizumab treatment of predominantly classic neovascular age-related macular degeneration in the 2-year anchor study.
Authors: Srinivas Sadda, David Boyer, Barbara Blodi
Publication Date: 2010-10
Lead Sponsor: Bionic Sight LLC
Intervention / Treatment: DRUG: BS01